CBG: The Promising Compound Derived from Cannabis

Cannabis plants produce a wide variety of compounds known as cannabinoids. While tetrahydrocannabinol (THC) and cannabidiol (CBD) have dominated headlines and research, another cannabinoid, cannabigerol (CBG), is emerging as a promising player in the field of medical science.

CBG is present in cannabis plants in much smaller quantities compared to other cannabinoids like cannabidiol (CBD) and tetrahydrocannabinol (THC). As a result, consumer products made from cannabigerol are rare and typically expensive. Despite this, CBG is gaining popularity due to its numerous potential benefits.

What is CBG?
Cannabigerol (CBG) is a non-psychoactive cannabinoid found in the cannabis plant. It is often referred to as the “mother of all cannabinoids” because it is the chemical precursor to other major cannabinoids like THC and CBD. In young cannabis plants, the first cannabinoid that forms is cannabigerolic acid (CBGA). This compound then changes into other important acids, which later turn into cannabinoids like THC and CBD. Therefore, without CBGA, the cannabis plant would not produce these other important cannabinoids.

How does it work?
Our body has two types of cannabinoid receptors: CB1 and CB2. CB1 receptors are found in the nervous system and brain, while CB2 receptors are located in the immune system and other parts of the body. CBG interacts with both receptors, potentially enhancing the function of anandamide, a neurotransmitter in the brain. Anandamide helps boost pleasure and motivation, regulate appetite and sleep, and reduce pain.

How and what for is CBG Used?
CBG is used in various forms, including oils, tinctures, capsules, and topical treatments. It is gaining popularity in the wellness industry for its potential therapeutic benefits.

CBG has shown promise in reducing inflammation, making it potentially useful for conditions like inflammatory bowel disease (IBD) and arthritis.

Preliminary research suggests that CBG may have neuroprotective effects, which could be beneficial in treating neurodegenerative diseases like Huntington’s disease and Parkinson’s disease.

CBG has been found to possess strong antibacterial properties, particularly against methicillin-resistant Staphylococcus aureus (MRSA), a significant concern in medical settings due to its resistance to many antibiotics.

Similar to THC but without the psychoactive effects, CBG has been found to increase appetite, which could help patients suffering from conditions like cancer or AIDS who experience severe appetite loss.

CBG is known to reduce intraocular pressure, making it a potential treatment for glaucoma.

Impact of CBG
The research of CBG does not only have impact on the therapeutic methods applied in healthcare, but also on the cannabis cultivating industry.

The impact of CBG on health and wellness is an area of active research. Its potential to treat a variety of conditions without the psychoactive effects makes it an attractive option for medical use. Patients looking for relief from chronic pain, inflammation, or neurological disorders may find CBG to be a valuable addition to their treatment regimen.

From an economic perspective, the increasing interest in CBG is also driving changes in the cannabis cultivation industry. Traditionally, cannabis plants are harvested later in their growth cycle to maximize THC or CBD content. However, CBG is more abundant in younger plants, prompting cultivators to harvest earlier or develop strains with higher CBG concentrations.

Clinical Trials and Scientific Research
While CBG is still in the early stages of scientific exploration compared to THC and CBD, CBG is emerging as a compound of interest due to its diverse pharmacological properties.

One of the most significant areas of CBG research is its anti-inflammatory effects. A study published in Biochemical Pharmacology in 2013, examined the effects of CBG on inflammatory bowel disease (IBD). It found that CBG reduced inflammation in mouse models of IBD. The researchers observed that CBG decreased the production of nitric oxide and reactive oxygen species in macrophages, which are cells involved in inflammatory responses. These findings suggest that CBG could be a promising treatment for IBD and other inflammatory conditions.

CBG has also shown potential in neuroprotection. A study published in Neurotherapeutics in 2015 investigated the neuroprotective properties of CBG in a mouse model of Huntington’s disease. The researchers discovered that CBG administration improved motor deficits and preserved striatal neurons, which are typically affected in Huntington’s disease. Additionally, CBG demonstrated anti-inflammatory and antioxidant properties, contributing to its neuroprotective effects. These results indicate that CBG could be a valuable therapeutic agent for neurodegenerative diseases.

CBG’s potential as an anti-cancer agent has also been investigated. A study published in Carcinogenesis in 2014 explored the effects of CBG on colorectal cancer cells in mice. The researchers found that CBG inhibited the growth of cancer cells and induced apoptosis, the process of programmed cell death. CBG was shown to downregulate genes associated with cancer cell proliferation and survival, suggesting its potential as a therapeutic agent for colorectal cancer. While these findings are preliminary, they provide a foundation for further research into CBG’s anti-cancer properties.

Another promising area of CBG research is its potential use in treating glaucoma. A study published in Experimental Eye Research in 2008 investigated the effects of CBG on intraocular pressure (IOP) in cats. The researchers found that CBG reduced IOP, which is a major risk factor for glaucoma. The study suggested that CBG could be a valuable treatment option for glaucoma, offering an alternative to traditional therapies.

CBG has also been studied for its effects on appetite. A 2016 study published in Psychopharmacology examined the appetite-stimulating properties of CBG in rats. The researchers found that CBG increased food intake without producing the psychoactive effects. This finding suggests that CBG could be beneficial for patients suffering from conditions that cause appetite loss, such as cancer or HIV/AIDS.

CBG: a Tool to Treat Various Conditions?
CBG is an exciting frontier in cannabinoid research, offering a broad spectrum of potential therapeutic benefits. While still in the nascent stages of scientific understanding, the evidence so far suggests that CBG could be instrumental in treating a range of conditions, from inflammation and neurodegeneration to bacterial infections and cancer. As research continues, CBG could give new hope for patients seeking alternative treatments.

As with any emerging treatment, it is essential for patients to consult healthcare professionals before starting any new regimen involving cannabinoids.

Source: https://www.mdpi.com/1422-0067/23/14/7929